SCHEMBL30392452

SCHEMBL30392452

COC(=O)c1nc(C2(NC(=O)OCc3ccccc3)CC2)n(C)c(=O)c1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RNASEH1 O60930 1/20 0.41
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38
CTSS P25774 1/20 0.38
PPIA P62937 1/20 0.38
ALDH1A1 P00352 4/20 0.37
KMT2A Q03164 3/20 0.37
TSHR P16473 6/20 0.37
CYP3A4 P08684 5/20 0.37
CYP2C9 P11712 4/20 0.37
CYP2C19 P33261 3/20 0.37
LMNA P02545 2/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
CYP1A2 P05177 2/20 0.37
MAPK1 P28482 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ERCC1 P07992 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30391919 0.82 TSHR (0.34) CTSLCTSBCTSSALDH1A1TSHR
SCHEMBL63048 0.79 HPGD (0.36) RNASEH1CTSLCTSBCTSSALDH1A1
SCHEMBL9942880 0.78 HPGD (0.35) CTSLCTSBCTSSALDH1A1KMT2A
SCHEMBL63519 0.78 OGFRL1 (0.41) KMT2ATSHRCYP3A4CYP2C9CYP2C19
SCHEMBL52246 0.77 HPGD (0.37) CTSLCTSBCTSSKMT2AMEN1
SCHEMBL8266635 0.76 KCNE1 (0.43) RNASEH1CTSSALDH1A1KMT2AMEN1
SCHEMBL1117837 0.76 CTSB (0.36) CTSLCTSBCTSSPPIATSHR
SCHEMBL9901321 0.75 SMN1; SMN2 (0.35) CTSLCTSBCTSSPPIAALDH1A1
SCHEMBL62151 0.74 ADORA3 (0.37) CTSLCTSBCTSS
SCHEMBL9900673 0.74 P2RX7 (0.34) KMT2ALMNAMEN1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250136588-A1 MODULATORS OF TREX1 CONSTELLATION PHARMACEUTICALS, INC. 2025-05-01 US disclosed
US-12172990-B2 Modulators of TREX1 CONSTELLATION PHARMACEUTICALS, INC. (US) 2024-12-24 US disclosed
EP-3891145-B1 MODULATORS OF TREX1 CONSTELLATION PHARMACEUTICALS INC (US) 2023-04-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250136588-A1 MODULATORS OF TREX1 TSNAX, TEAD1, TMX1 RNASEH1 753/4885CTSL 905/4885CTSB 688/4885
US-12172990-B2 Modulators of TREX1 CFTR, SLC10A1, CYP27A1 RNASEH1 1364/4885CTSL 4375/4885CTSB 2403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.